References
- Fallon M , GiustiR , AielliFet al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann. Oncol.29(Suppl. 4), iv166–iv191 (2018).
- Greco MT , RobertoA , CorliOet al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J. Clin. Oncol.32(36), 4149–4154 (2014).
- Managing Advanced Cancer Pain Together . Managing Advanced Cancer Pain Together (MACPT): an expert guidance. http://www.macpt.info/download/J009950_CME1029_Pain_Guidence_Doc.pdf
- Quinn B , LuftnerD , DiPalma M , DarganS , DalLago L , Drudges-CoatesL. Managing pain in advanced cancer settings: an expert guidance and conversation tool. Cancer Nursing Practice16(10), 27–34 (2017).
- Mendoza TR , DueckAC , ShiQet al. The contribution of pain in determining the health status of cancer patients with bone metastases: a secondary analysis of data from three Phase III registration trials. Eur. J. Pain.22(3), 565–571 (2018).
- Coluzzi F , RolkeR , MercadanteS. Pain management in patients with multiple myeloma: an update. Cancers (Basel)11(12), 2037 (2019).
- Von Moos R , BodyJJ , EgerdieBet al. Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support. Care Cancer21(12), 3497–3507 (2013).
- What is cancer pain? https://www.esmo.org/for-patients/patient-guides/cancer-pain-management
- Hulin C , HansenT , HeronLet al. Living with the burden of relapse in multiple myeloma from the patient and physician perspective. Leuk. Res.59, 75–84 (2017).
- Anderson P , BenfordM , HarrisN , KaravaliM , PiercyJ. Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand. Curr. Med. Res. Opin.24(11), 3063–3072 (2008).
- Babineaux SM , CurtisB , HolbrookT , MilliganG , PiercyJ. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme. BMJ Open6(8), e010352 (2016).
- Higgins V , PiercyJ , RoughleyAet al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab. Syndr. Obes.9, 371–380 (2016).
- Brooks R . EuroQol: the current state of play. Health Policy37(1), 53–72 (1996).
- Fayers PM , AaronsonNK , BjordalKet al. The European Organisation for Research and Treatment of Cancer QLQ-C30: Aquality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst.85, 365–376 (1993).
- Cocks K , CohenD , WisloffFet al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur. J. Cancer43(11), 1670–1678 (2007).
- Giesinger JM , LothFLC , AaronsonNKet al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J. Clin. Epidemiol. doi:10.1016/j.jclinepi.2019.10.003 (2019) ( Epub ahead of print).
- European Pharmaceutical Market Research Association . Code of conduct. https://www.ephmra.org/standards/code-of-conduct/
- United States Department of Health and Human Services . Summary of the HIPAA privacy rule. http://www.hhs.gov/sites/default/files/privacysummary.pdf
- United States Department of Health and Human Services . Health Information Technology Act. https://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf
- Landis JR , KochGG. The measurement of observer agreement for categorical data. Biometrics33(1), 159–174 (1977).
- Xiao C , PolomanoR , BrunerDW. Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs.36(6), E1–E16 (2013).
- Managing Advanced Cancer Pain Together . Managing advanced cancer pain together conversation tool. http://www.macpt.info/guidance.php
- Ludwig M , BaileyAL , MarongiuAet al. Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice. Cancer Reportse1429 (2021).
- Tariman JD , DoorenbosA , ScheppKG , BeckerPS , BerryDL. Patient, physician and contextual factors are influential in the treatment decision making of older adults newly diagnosed with symptomatic myeloma. Cancer Treat Commun.2(2-3), 34–47 (2014).
- Kiely F , CranA , FinnertyD , O’brienT. Self-reported quality of life and symptom burden in ambulatory patients with multiple myeloma on disease-modifying treatment. Am. J. Hosp. Palliat. Care34(7), 671–676 (2017).
- Rome S , NoonanK , BertolottiP , TarimanJD , MiceliT. Bone health, pain, and mobility: evidence-based recommendations for patients with multiple myeloma. Clin. J. Oncol. Nurs.21(Suppl. 5), 47–59 (2017).
- Coleman R , HadjiP , BodyJJet al. Bone health in cancer: ESMO Clinical Practice Guidelines. Ann. Oncol.31(12), 1650–1663 (2020).
- Gilligan T , CoyleN , FrankelRMet al. Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. J. Clin. Oncol.35(31), 3618–3632 (2017).
- Whitten CE , EvansCM , CristobalK. Pain management doesn’t have to be a pain: working and communicating effectively with patients who have chronic pain. Perm. J.9(2), 41–48 (2005).
- Raphael J , HesterJ , AhmedzaiSet al. Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain. Med.11(6), 872–896 (2010).
- Leblanc TW , BaileWF , EgglySet al. Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies. Patient Educ. Couns.102(9), 1602–1612 (2019).
- Zaleta AK , MillerMF , JohnsonJet al. Symptom burden, palliative care needs, and patient-provider communication among chronic myeloid leukemia survivors. Blood130, 4704 (2017).
- Baz R , LinHM , HuiAMet al. Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life. Support. Care Cancer23(9), 2789–2797 (2015).
- Carlson KB , FloraDR , LoweKet al. Findings from the Bone Health Education Needs assessment (BEACON) Study: a survey of multiple myeloma and bone metastatic solid tumor patients at risk for skeletal-related events. Presented at: Journal of the Advanced Practitioner in Oncology.Seattle, Washington, USA, 24–27 October 2019.